Misoplegia and dementia: a case study
Diogo Haddad Santos1,2, Yngrid Dieguez Ferreira1,2, Gilvan Guersoni Hora1
1Irmandade da Santa Casa de Misericórdia de São Paulo - São Paulo, SP, Brazil.
Dementia & Neuropsychologia
|August 4, 2021
Summary
Misoplegia, a condition causing aversion to an impaired limb, is rare. This case report details a patient with misoplegia and vascular dementia, highlighting the need for more research into this unusual neurological deficit.
Area of Science:
- Neurology
- Psychiatry
- Neuropsychology
Background:
- Brain damage can lead to unusual psychological responses to physical deficits.
- Misoplegia is characterized by intense aversion and hostility towards an affected limb.
- Existing literature on misoplegia is limited, necessitating case reports for better understanding.
Observation:
- The case involves a patient diagnosed with vascular dementia.
- The patient exhibited symptoms consistent with misoplegia, including exaggerated aversion to an impaired limb.
- Behavioral manifestations included hatred of paresis and directed abuse towards the paretic limb.
Findings:
- This report presents a rare case of misoplegia co-occurring with vascular dementia.
- The patient's presentation underscores the complex interplay between cognitive decline and psychological disturbances post-brain injury.
- The case highlights the potential for misoplegia to manifest in neurodegenerative conditions.
Implications:
- Further research is needed to explore the pathophysiology and prevalence of misoplegia.
- Understanding misoplegia in dementia patients can improve patient care and therapeutic strategies.
- This case contributes to the limited body of knowledge on misoplegia, aiding in diagnosis and management.
More Related Videos
Related Concept Videos
01:30Dementia
255
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
255
01:12Visual Agnosia
482
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
482
01:26Alzheimer's Disease: Overview
877
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
877
01:24Prosopagnosia
408
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
408
01:22Alzheimer's Disease: Treatment
416
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
416
01:21Dissociative Amnesia
215
Dissociative amnesia is a complex psychological condition that manifests as an inability to recall personal information, often tied to traumatic or stressful events. Unlike general amnesia, individuals with this condition retain the ability to perform routine activities and procedural tasks, such as operating a phone or navigating public transportation, yet experience profound gaps in autobiographical memory. These lapses may encompass significant life events, such as suicide attempts or...
215